These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 25440912)

  • 1. An alternative approach to the prevention of doping in cycling.
    Aubel O; Ohl F
    Int J Drug Policy; 2014 Nov; 25(6):1094-102. PubMed ID: 25440912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The team effect on doping in professional male road cycling (2005-2016).
    Aubel O; Lefèvre B; Le Goff JM; Taverna N
    Scand J Med Sci Sports; 2019 Apr; 29(4):615-622. PubMed ID: 30636331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The development of doping use in high-level cycling: from team-organized doping to advances in the fight against doping.
    Lentillon-Kaestner V
    Scand J Med Sci Sports; 2013 Mar; 23(2):189-97. PubMed ID: 22092601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Condemning and condoning: Elite amateur cyclists' perspectives on drug use and professional cycling.
    Outram SM; Stewart B
    Int J Drug Policy; 2015 Jul; 26(7):682-7. PubMed ID: 25666447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doping risk and career turning points in male elite road cycling (2005-2016).
    Aubel O; Lefèvre B; Le Goff JM; Taverna N
    J Sci Med Sport; 2018 Oct; 21(10):994-998. PubMed ID: 29580881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [What the Japan Cycling Federation hopes to accomplish in cooperation with pharmacists in doping and implementing effective anti-doping controls?].
    Sakamoto Y
    Yakugaku Zasshi; 2011; 131(12):1747-9. PubMed ID: 22129870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doping use among young elite cyclists: a qualitative psychosociological approach.
    Lentillon-Kaestner V; Carstairs C
    Scand J Med Sci Sports; 2010 Apr; 20(2):336-45. PubMed ID: 19486486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current anti-doping policy: a critical appraisal.
    Kayser B; Mauron A; Miah A
    BMC Med Ethics; 2007 Mar; 8():2. PubMed ID: 17394662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Speed trends of major cycling races: does slower mean cleaner?
    Perneger TV
    Int J Sports Med; 2010 Apr; 31(4):261-4. PubMed ID: 20148370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of doping control test results in individual and team sports from 2003 to 2015.
    Aguilar-Navarro M; Muñoz-Guerra J; Del Mar Plara M; Del Coso J
    J Sport Health Sci; 2020 Mar; 9(2):160-169. PubMed ID: 32099724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health and doping in elite-level cycling.
    Lentillon-Kaestner V; Hagger MS; Hardcastle S
    Scand J Med Sci Sports; 2012 Oct; 22(5):596-606. PubMed ID: 21392123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A forensic perspective of the AFL investigation into peptides: an antidoping investigation case study.
    Harcourt PR; Marclay F; Clothier B
    Br J Sports Med; 2014 May; 48(10):810-3. PubMed ID: 24642697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doping control analyses in horseracing: a clinician's guide.
    Wong JK; Wan TS
    Vet J; 2014 Apr; 200(1):8-16. PubMed ID: 24485918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of caffeine levels in urine in different sports in relation to doping control before and after the removal of caffeine from the WADA doping list.
    Van Thuyne W; Delbeke FT
    Int J Sports Med; 2006 Sep; 27(9):745-50. PubMed ID: 16586337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attitudes towards doping and related experience in Spanish national cycling teams according to different Olympic disciplines.
    Morente-Sánchez J; Mateo-March M; Zabala M
    PLoS One; 2013; 8(8):e70999. PubMed ID: 23990919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fight against doping--national and international developments after Tour de France 1998].
    Kamber M
    Ther Umsch; 2001 Apr; 58(4):220-5. PubMed ID: 11344953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioethics, sport and the genetically enhanced athlete.
    Miah A
    Med Etika Bioet; 2002; 9(3-4):2-6. PubMed ID: 16285154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Doping in sport].
    Schänzer W; Thevis M
    Med Klin (Munich); 2007 Aug; 102(8):631-46. PubMed ID: 17694283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some empirical notes on the epo epidemic in professional cycling.
    Lodewijkx HF; Brouwer B
    Res Q Exerc Sport; 2011 Dec; 82(4):740-54. PubMed ID: 22276416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prioritising health in anti-doping: what Australians think.
    Mazanov J; Huybers T; Connor J
    J Sci Med Sport; 2012 Sep; 15(5):381-5. PubMed ID: 22613257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.